{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T13:16:35Z","timestamp":1788786995072,"version":"build-2803163510"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T00:00:00Z","timestamp":1736294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Chronic hepatitis B and cirrhosis pose significant global health threats. Few studies have explored the disease burden and mortality trend of cirrhosis caused by hepatitis B virus infection among adolescents and young adults (AYAs, aged 15\u201339\u202fyears). This study aimed to assess the disease burden and trends.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Publicly available data were obtained from the 2021 GBD database. The rates of incidence, mortality, and disability-adjusted life years were calculated at the global, regional, and national levels. Temporal trends were assessed using joinpoint regression analysis, while the Bayesian age-period-cohort model was used to predict future trends.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>From 1990 to 2021, the global incidence rate of hepatitis B-related cirrhosis decreased from 111.33 (95% uncertainty interval: 89.18 to 134.98) to 67.75 (54.06 to 82.71) per 100,000 with an average annual percentage change of \u22121.58 (95% confidence interval: \u22121.66 to \u22121.51, <jats:italic>p<\/jats:italic> &amp;lt;\u202f0.001). However, between 1990 and 2021, the incidence numbers in the 30\u201334 and 35\u201339 age groups increased by 23.75 and 21.24%, respectively. The number of deaths in low and low-middle Socio-demographic Index (SDI) areas increased by 79.51 and 20.62%, respectively. Moreover, it is predicted that the numbers of incidences and deaths will continue to rise in areas with low SDI. At the regional level, Central Sub-Saharan Africa had the highest incidence and mortality rates. In 2021, Somalia and the Democratic Republic of Congo had the highest incidence rates, whereas Kiribati and Cambodia had the highest mortality rates.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The overall burden of hepatitis B-related cirrhosis among AYAs has decreased over the past three decades. Nevertheless, there was a slight increase in the incidence number among individuals aged 30\u201339\u202fyears. The substantial burden and predicted rise in the numbers of incidences and deaths in low SDI areas underscore the need for sustained and targeted public health interventions.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpubh.2024.1494388","type":"journal-article","created":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T06:21:09Z","timestamp":1736317269000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Global temporal trends and projections of hepatitis B-related cirrhosis among adolescents and young adults from 1990 to 2035: an analysis based on the global burden of disease study 2021"],"prefix":"10.3389","volume":"12","author":[{"given":"Quanwei","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiujuan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sihao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujuan","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiagan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangtao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rugang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,8]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/S2468-1253(22)00124-8","article-title":"Global, regional, and national burden of hepatitis B, 1990\u20132019: a systematic analysis for the global burden of disease study 2019","volume":"7","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.3390\/ijms20061358","article-title":"Molecular mechanisms driving progression of liver cirrhosis towards hepatocellular carcinoma in chronic hepatitis B and C infections: a review","volume":"20","author":"Kanda","year":"2019","journal-title":"Int J Mol Sci"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/s41575-023-00759-2","article-title":"Global epidemiology of cirrhosis \u2014 aetiology, trends and predictions","volume":"20","author":"Huang","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref4","year":""},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1002\/cam4.4551","article-title":"Global burden of primary liver cancer by five etiologies and global prediction by 2035 based on global burden of disease study 2019","volume":"11","author":"Liu","year":"2022","journal-title":"Cancer Med"},{"key":"ref6","year":""},{"key":"ref7","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.jhep.2007.11.011","article-title":"Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors","volume":"48","author":"Fattovich","year":"2008","journal-title":"J Hepatol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jhep.2008.07.023","article-title":"Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B","volume":"50","author":"Yuen","year":"2009","journal-title":"J Hepatol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"e28858","DOI":"10.1002\/jmv.28858","article-title":"Trends in the incidence of cirrhosis in global from 1990 to 2019: a joinpoint and age-period-cohort analysis","volume":"95","author":"Wu","year":"2023","journal-title":"J Med Virol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/jvh.13618","article-title":"Liver fibrosis scores and risk of liver-related mortality in young adults with chronic hepatitis B: a cohort study","volume":"29","author":"Sohn","year":"2022","journal-title":"J Viral Hepat"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1002\/hep.29068","article-title":"Nonalcoholic fatty liver disease in adolescents and young adults: the next frontier in the epidemic","volume":"65","author":"Doycheva","year":"2017","journal-title":"Hepatology"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/jvh.13903","article-title":"International disease burden of acute viral hepatitis among adolescents and young adults: an observational study","volume":"31","author":"Yang","year":"2024","journal-title":"J Viral Hepat"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/apt.18101","article-title":"Global epidemiology of alcohol-associated liver disease in adolescents and young adults","volume":"60","author":"Danpanichkul","year":"2024","journal-title":"Aliment Pharmacol Ther"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1002\/hep.32228","article-title":"Global burden of NAFLD and chronic liver disease among adolescents and young adults","volume":"75","author":"Paik","year":"2022","journal-title":"Hepatol Baltim Md"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","article-title":"Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the global burden of disease study 2021","volume":"403","year":"2024","journal-title":"Lancet Lond Engl"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"3102","DOI":"10.1002\/sim.9407","article-title":"Twenty years since Joinpoint 1.0: two major enhancements, their justification, and impact","volume":"41","author":"Kim","year":"2022","journal-title":"Stat Med"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.3390\/jcm12051828","article-title":"The global burden of glaucoma: findings from the global burden of disease 2019 study and predictions by Bayesian age\u2013period\u2013cohort analysis","volume":"12","author":"Lin","year":"2023","journal-title":"J Clin Med"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S2468-1253(19)30349-8","article-title":"The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990\u20132017: a systematic analysis for the global burden of disease study 2017","volume":"5","author":"Sepanlou","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1007\/s12072-023-10531-y","article-title":"Global, regional, and national burdens of cirrhosis in children and adolescents aged under 19 years from 1990 to 2019","volume":"18","author":"Zhang","year":"2024","journal-title":"Hepatol Int"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.jhep.2021.04.035","article-title":"Global burden of acute viral hepatitis and its association with socioeconomic development status, 1990-2019","volume":"75","author":"Zeng","year":"2021","journal-title":"J Hepatol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"994619","DOI":"10.3389\/fpubh.2022.994619","article-title":"Long-term trends in the burden of inflammatory bowel disease in China over three decades: a joinpoint regression and age-period-cohort analysis based on GBD 2019","volume":"10","author":"Zhang","year":"2022","journal-title":"Front Public Health"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1002\/cac2.12197","article-title":"Cancer incidence, mortality, and burden in China: a time-trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020","volume":"41","author":"Qiu","year":"2021","journal-title":"Cancer Commun Lond Engl"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1002\/bimj.201500263","article-title":"Projecting the future burden of cancer: Bayesian age\u2013period\u2013cohort analysis with integrated nested Laplace approximations","volume":"59","author":"Riebler","year":"2017","journal-title":"Biom J"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.atherosclerosis.2022.03.002","article-title":"Global death burden and attributable risk factors of peripheral artery disease by age, sex, SDI regions, and countries from 1990 to 2030: results from the global burden of disease study 2019","volume":"347","author":"Liu","year":"2022","journal-title":"Atherosclerosis"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1093\/ije\/dyaa196","article-title":"Global trend of aetiology-based primary liver cancer incidence from 1990 to 2030: a modelling study","volume":"50","author":"Liu","year":"2021","journal-title":"Int J Epidemiol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.jcv.2012.08.022","article-title":"Viral hepatitis: global goals for vaccination","volume":"55","author":"Lavanchy","year":"2012","journal-title":"J Clin Virol Off Publ Pan Am Soc Clin Virol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1016\/j.cgh.2022.05.045","article-title":"Trends in etiology-based mortality from chronic liver disease before and during COVID-19 pandemic in the United States","volume":"20","author":"Kim","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"100531","DOI":"10.1016\/j.jhepr.2022.100531","article-title":"Impact of the COVID-19 pandemic on hepatitis B and C elimination: an EASL survey","volume":"4","author":"Kondili","year":"2022","journal-title":"JHEP Rep"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.3390\/cells12121604","article-title":"The influence of sex hormones in liver function and disease","volume":"12","author":"Kasarinaite","year":"2023","journal-title":"Cells"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1002\/hep.24442","article-title":"Elimination of hepatocellular carcinoma and acute hepatitis B in children 25 years after a hepatitis B newborn and catch-up immunization program","volume":"54","author":"McMahon","year":"2011","journal-title":"Hepatol Baltim Md"},{"key":"ref31","year":"2016"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"288","DOI":"10.3390\/vaccines12030288","article-title":"Global perspectives on the hepatitis B vaccination: challenges, achievements, and the road to elimination by 2030","volume":"12","author":"Al-Busafi","year":"2024","journal-title":"Vaccine"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41575-022-00688-6","article-title":"Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors","volume":"20","author":"Huang","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S1470-2045(21)00581-7","article-title":"The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the global burden of disease study 2019","volume":"23","year":"2022","journal-title":"Lancet Oncol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/S2468-1253(20)30011-X","article-title":"Do the most heavily burdened countries have the right policies to eliminate viral hepatitis B and C?","volume":"5","author":"Palayew","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"726","DOI":"10.12449\/JCH240414","article-title":"Changing trend of the disease burden of liver cirrhosis in China from 1990 to 2019","volume":"40","author":"Liu","year":"2024","journal-title":"J Clin Hepatol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12072-015-9675-4","article-title":"Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update","volume":"10","author":"Sarin","year":"2015","journal-title":"Hepatol Int"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1007\/s12072-016-9745-2","article-title":"Hepatitis B virus genotypes: epidemiological and clinical relevance in Asia","volume":"10","author":"Tian","year":"2016","journal-title":"Hepatol Int"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"e715","DOI":"10.1016\/S2214-109X(23)00131-6","article-title":"Risk of early horizontal transmission of hepatitis B virus in children of uninfected mothers in sub-Saharan Africa: a systematic review and meta-analysis","volume":"11","author":"Ansari","year":"2023","journal-title":"Lancet Glob Health"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1016\/j.jhep.2022.07.018","article-title":"Entecavir plus Biejia-Ruangan compound reduces the risk of hepatocellular carcinoma in Chinese patients with chronic hepatitis B","volume":"77","author":"Ji","year":"2022","journal-title":"J Hepatol"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2024.1494388\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T06:21:14Z","timestamp":1736317274000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2024.1494388\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,8]]},"references-count":40,"alternative-id":["10.3389\/fpubh.2024.1494388"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2024.1494388","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,8]]},"article-number":"1494388"}}